Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/02/2009EP1633759B1 Cross-linked glycopeptide-cephalosporin antibiotics
12/02/2009EP1626050B1 Sulfur-containing naphthoylimide derivatives
12/02/2009EP1622875B1 Crystalline forms of an arylaniline beta-2 adrenergic receptor agonist
12/02/2009EP1618086B1 Compounds for the treatment of metabolic disorders
12/02/2009EP1606284B1 Compositions useful as protein kinase inhibitors
12/02/2009EP1583742B1 Cb 1 receptour inverse agonists
12/02/2009EP1581477B1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/02/2009EP1551827B1 Piperidine derivatives as ccr5 inhibitors
12/02/2009EP1551802B1 Indole-3-sulphur derivatives
12/02/2009EP1542984B1 Methods of purifying cannabinoids from plant material
12/02/2009EP1542684B1 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
12/02/2009EP1534670B1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs
12/02/2009EP1523321B1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
12/02/2009EP1503763B1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
12/02/2009EP1487416B1 Drug microparticles
12/02/2009EP1463440B1 Prevention of flap necrosis in plastic surgery
12/02/2009EP1446380B1 Formoterol tartrate process and polymorph
12/02/2009EP1435909B1 Stable composition comprising particles in a frozen aqueous matrix
12/02/2009EP1434765B1 Substituted piperidines with selective binding to histamine h3-receptor
12/02/2009EP1414459B1 Oral dosage form comprising a therapeutic agent and an adverse-effect agent
12/02/2009EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009EP1389203B1 Analogs of thalidomide as angiogenesis inhibitors
12/02/2009EP1370270B1 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
12/02/2009EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009EP1322748B1 Stem cell differentiation-inducing promoter
12/02/2009EP1309726B1 Rna sequence-specific mediators of rna interference
12/02/2009EP1272179B1 Hydrophilic molecular disperse solutions of carvedilol
12/02/2009CN101595119A Crystalline forms of 11 beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17- hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one
12/02/2009CN101595115A Organo-arsenoxide compounds and use thereof
12/02/2009CN101595111A Selective glycosidase inhibitors and uses thereof
12/02/2009CN101595110A 7-substituted purine derivatives for immunosuppression
12/02/2009CN101595109A 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods
12/02/2009CN101595107A Substituted piperidines that increase P53 activity and the uses thereof
12/02/2009CN101595106A Substituted gamma lactams as therapeutic agents
12/02/2009CN101595105A 2-substituted 5-membered heterocycles as SCD inhibitors
12/02/2009CN101595104A Novel crystalline compound useful as GLK activator
12/02/2009CN101595103A Pyrimidine derivatives
12/02/2009CN101595102A Biaryl ether urea compounds
12/02/2009CN101595101A Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
12/02/2009CN101595100A Heterocyclic-substituted piperidine as ORL-1 ligands
12/02/2009CN101595099A Crystalline duloxetine hydrochloride
12/02/2009CN101595098A 1,2,4-triazole derivatives as sigma receptor inhibitors
12/02/2009CN101595096A Substituted carbinol compound
12/02/2009CN101595095A 18, 21-didesoxymacbecin derivatives for the treatment of cancer
12/02/2009CN101595094A Cycloalkylamine substituted isoquinolone derivatives
12/02/2009CN101595093A Organic compounds
12/02/2009CN101595092A Methods of synthesizing pharmaceutical salts of a factor XA inhibitor
12/02/2009CN101595091A 1-naphthyl alkylpiperidine derivative
12/02/2009CN101595090A Process for the preparation of pleuromutilins
12/02/2009CN101595088A Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
12/02/2009CN101595084A Biaryl compositions and methods for modulating a kinase cascade
12/02/2009CN101595083A [F-18]-labeled l-glutamic acid, [F-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation
12/02/2009CN101594909A IRAK modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
12/02/2009CN101594884A Protective agent for retinal nerve or optic nerve
12/02/2009CN101594875A Methods and formulations for improved bioavalability of antiprogestins
12/02/2009CN101594874A 6-alkoxyalkyl estradiol derivatives and methods of use
12/02/2009CN101594873A Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue
12/02/2009CN101594872A Prostaglandin E2 (PGE2) as an adjuvant in monoclonal antibody generation
12/02/2009CN101594871A Pyrrolopyrimidine compounds and their uses
12/02/2009CN101594870A 4-aminoquinazoline derivatives and methods of use thereof
12/02/2009CN101594869A Thioxanthene derivates usefulto treat infectious diseases
12/02/2009CN101594868A A pharmaceutical composition having antipsychotic, antidepressant or antiepiieptic activity with reduced side effect
12/02/2009CN101594867A Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance
12/02/2009CN101594866A Topical formulations
12/02/2009CN101594865A Pharmaceutical composition containing low-substituted hydroxypropylcellulose
12/02/2009CN101594864A Method for producing solid preparation
12/02/2009CN101594863A Film-coated preparation having improved stability
12/02/2009CN101594862A Substituted indazole derivatives active as kinase inhibitors
12/02/2009CN101594861A Modulation of prostaglandin/cyclooxygenase metabolic pathways
12/02/2009CN101594860A Adam inhibitor
12/02/2009CN101594859A Compositions comprising carnosic acid 12-methylether
12/02/2009CN101594858A Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders
12/02/2009CN101594857A Crystalline forms of aliskiren hemifumarate
12/02/2009CN101594856A Agent and method for preventing and treating intoxication by alcohol-containing liquids and alcohol substitutes
12/02/2009CN101594855A Muscarinic agonists to treat impulse control disorders
12/02/2009CN101594853A Modified release ibuprofen solid oral dosage form
12/02/2009CN101594852A Melt-processed imatinib dosage form
12/02/2009CN101594851A Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
12/02/2009CN101594850A Antilipidemic pharmaceutical compositions and process for preparation thereof
12/02/2009CN101594790A Novel use of (-)-epigallocatechin gallate
12/02/2009CN101594780A Agents for controlling parasites on animals
12/02/2009CN101594778A Non-standard amino acid conjugates of amphetamine and processes for making and using the same
12/02/2009CN101591377A Aminoacyl-phenylalanyl-tryptophan or derivative, synthetic method and application thereof
12/02/2009CN101591375A Compound with analgesic activity, preparation method and application thereof
12/02/2009CN101591374A Steroid compound, preparation method thereof, medicinal composition containing compound and application of compounds
12/02/2009CN101591369A N-glycosyl-3-aryl acrylamide derivative, preparation method and medical function thereof
12/02/2009CN101591368A Girald pteroxygonum root neoflavonoid compound
12/02/2009CN101591364A Amino sugar derivative, preparation method thereof and medicinal application thereof
12/02/2009CN101591357A Group of phosphate/phosphate ester compounds for inhibiting BCR-ABL kinase
12/02/2009CN101591350A Group of boric acid/boric acid ester compounds for inhibiting BCR-ABL kinase
12/02/2009CN101591348A Tetrahydrochysene carboline acyl aminoacid benzyl ester, preparation method and application thereof
12/02/2009CN101591347A Cefixime acid type double salt compound and preparation method thereof
12/02/2009CN101591344A Antithrombotic compound as well as preparation method and application thereof
12/02/2009CN101591341A Alkyl porphyrin compound, preparation and application thereof in field of medicaments and pesticides
12/02/2009CN101591340A 5,10,15,20-tetra-(5-drewamine amyl)-chlorin, preparation and application thereof in field of medicaments and pesticides
12/02/2009CN101591337A Compound formed by splicing ferulic acid and matrine compound and application thereof
12/02/2009CN101591335A N-(L-aminoacyl)-1, 2, 3, 4-tetrahydrochysene carboline acyl aminoacid benzyl ester, synthetic method and application thereof
12/02/2009CN101591333A Method for purifying pseudomonas acid A
12/02/2009CN101591332A Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof
12/02/2009CN101591327A Benzene alkyl amides compound and usage thereof
1 ... 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 ... 7860